SNIPR's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology.
SNIPR has research findings published in Nature Biotechnology
Previous
Previous
Precedential US Federal Court Decision Hands SNIPR a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing
Next
Next